Beijing 2022 – The ITA asserts an apparent anti-doping rule violation against Ukrainian athlete Lidiia Hunko

The AAF¹ returned for the non-specified prohibited substance dehydrochloromethyl-testosterone metabolite 4α-chloro-18-nor-17β-hydroxymethyl, 17α-methyl-5α-androst-13-en-3α-ol (LTM M3), according to the Prohibited List of the World Anti-Doping Agency (WADA).

The sample was collected by the ITA under the testing authority and results management authority of the International Olympic Committee (IOC) during an in-competition anti-doping control on 14 February 2022 in Yanqing, China. The result was reported by the WADA-accredited laboratory of Beijing on 17 February 2022.

The athlete has been informed of the case and has been provisionally suspended until the resolution of the matter in line with the World Anti-Doping Code and the IOC Anti-Doping Rules applicable to the Olympic Winter Games Beijing 2022. This means that the athlete is prevented from competing, training, coaching, or participating in any activity, during the Olympic Winter Games Beijing 2022.

The athlete has the right to challenge the imposition of the provisional suspension before the Court of Arbitration for Sport – Anti-Doping Division (CAS ADD).

The athlete also has the right to request the analysis of the B-sample.

Given that the case is underway, there will be no further comments during the ongoing proceeding.